Wißt Theresa, Jehn Christian-Friedrich, Vierbuchen Mathias, Starekova Jitka
Department of Cardiology, Asklepios Klinik St. Georg, Lohmühlenstr. 5, Hamburg, Germany.
Department of Haematology and Oncology, Asklepios Klinik St. Georg, Lohmühlenstr. 5, Hamburg, Germany.
Eur Heart J Case Rep. 2018 Sep 12;2(3):yty096. doi: 10.1093/ehjcr/yty096. eCollection 2018 Sep.
Cardiac tumours are of rare incidence and usually occur in the form of secondary tumours. Most metastatic tumours are melanomas, sarcomas, lung, and haematological malignancies. Neuroendocrine carcinomas (NECs) of the heart are extremely unusual. This case report demonstrates a solitary high-grade NEC of the heart with an individual therapy strategy and follow-up.
A 50-year-old gentleman presented with a 2 days history of recurrent episodes of chest pain. Echocardiography, computed tomography, and magnetic resonance imaging revealed tumorous lesions of the ventricles and aortic valve with large circular pericardial effusion. Histopathology results of the biopsy revealed a poorly differentiated small cell tumour of the neuroendocrine type. Despite further investigations with multiple imaging modalities and laboratory, no primary was found. Chemotherapy was initiated but size progression of the tumour was detected. As no other tumorous lesions were detected and resection was not possible because of the tumour complexity, decision on heart transplantation was made. However, due to the necessary immunosuppression after the heart transplantation, multiple metastasis where discovered in the course of treatment.
The presence of a NEC in the heart without evidence of any other metastasis or evidence of primary tumour in other organs is clinically unique. For this individual case, heart transplantation was the therapy of choice due to tumour progression under chemotherapy and lacking possibility of resection, as no other suspect lesion was found other than the ones found in the heart. However, the risk of exacerbation of undiscovered micrometastases under necessary immunosuppression following the heart transplantation should be considered.
心脏肿瘤发病率较低,通常以继发性肿瘤的形式出现。大多数转移性肿瘤为黑色素瘤、肉瘤、肺癌和血液系统恶性肿瘤。心脏神经内分泌癌(NEC)极为罕见。本病例报告展示了一例心脏孤立性高级别NEC,并介绍了个体化治疗策略及随访情况。
一名50岁男性,有2天反复发作胸痛的病史。超声心动图、计算机断层扫描和磁共振成像显示心室和主动脉瓣有肿瘤性病变,并伴有大量圆形心包积液。活检的组织病理学结果显示为神经内分泌型低分化小细胞肿瘤。尽管进行了多种影像学检查和实验室检查,仍未发现原发灶。开始化疗,但肿瘤大小仍有进展。由于未检测到其他肿瘤性病变,且因肿瘤复杂无法进行切除,遂决定进行心脏移植。然而,由于心脏移植后需要进行免疫抑制,在治疗过程中发现了多处转移。
心脏中存在NEC,而无任何其他转移证据或其他器官原发肿瘤证据,这在临床上是独特的。对于该个体病例,由于化疗后肿瘤进展且无法切除,而心脏外未发现其他可疑病变,心脏移植是首选治疗方法。然而,应考虑心脏移植后必要免疫抑制下未发现的微转移灶恶化的风险。